Role: DOGE health-agency operations lead at HHS, 2025 — architect of approximately $67 billion in HHS cuts (STAT News, June 2, 2025); founder and CEO of healthcare startup firm Russell Street Ventures; previously Director of the Center for Medicare and Medicaid Innovation (CMMI) during the first Trump administration. Effectively co-ran DOGE alongside Musk and Vivek Ramaswamy during the earliest days. Returned to the Trump administration in a subsequent role (Semafor, August 12, 2025).

Basis for Inclusion

Subject classification: Voluntary Public Figure (private investor returned to federal role).

Anchor met: Anchor B / Anchor E — operational coordinator with documented agency-restructuring authority.

Background

Smith was a healthcare-policy operator and investor who served as CMMI Director under Trump 1.0. He maintained healthcare investment positions and returned to federal-government work in 2025 as DOGE’s health-agency operations lead.

DOGE Role

• Directed DOGE restructuring of HHS, CMS, FDA, CDC, and NIH (per WIRED, NYT, ProPublica reporting, 2025).
• Coordinated workforce reductions, contract terminations, and program eliminations across the federal health portfolio.

Documented Actions

• Coordinated NIH 1,200 STEM/R&D job eliminations, FDA 3,500, CDC 3,000 (per November 5, 2025 congressional letter to Vought).
• Directed CMMI program reorganization including alternative-payment-model cancellations.

Real-World Impacts

Federal Employees

• Health-agency RIFs concentrated at HHS — the agency that experienced the largest share of the formal 10,700 federal RIFs in 2025 (OpenFeds, November 2025).

American Citizens (Public Services)

• Reduced FDA drug-review capacity affected pending drug applications.
• CDC infectious-disease surveillance and outbreak response capacity reduced.
• NIH grant review delays affected biomedical research nationally.

Vulnerable Populations

• Medicaid and Medicare beneficiaries affected by CMS restructuring.
• Patients dependent on FDA drug approval timelines.

Privacy and Data Security

• HHS contains sensitive health data including Medicare/Medicaid enrollment records. DOGE personnel obtained access during Smith’s tenure.

Other Documented Harms

• Reduced public-health infrastructure capacity heading into the 2025-2026 respiratory season raised concerns from public-health experts (multiple journal commentaries; CDC oversight letters).

Conflicts of Interest

• Russell Street Ventures: Smith’s own healthcare-startup firm holds positions in companies whose regulatory environment is set by the HHS sub-agencies he restructured.
• CMS favoritism allegation: Per Politico (via Revolving Door Project), Smith reportedly slowed planned HHS cuts at CMS — the agency where he previously served as CMMI Director — while making deeper cuts elsewhere across HHS, raising favoritism concerns.

Sources

• STAT News, “DOGE’s Brad Smith: The little-known architect of $67B in HHS cuts,” June 2, 2025
• STAT News / Health Care Inc., “DOGE’s Brad Smith profile” newsletter, June 2, 2025
• Revolving Door Project, “DOGE Agent: Brad Smith,” 2025
• Semafor, “Former senior DOGE official returns to the Trump administration,” August 12, 2025
• Inside Medicine substack, “The calm before the chainsaw at HHS,” 2025
• WIRED, NYT, ProPublica DOGE health coverage, 2025
• Congressional letter to Vought, November 5, 2025
• OpenFeds DOGE Impact Dashboard, November 2025
• Senate HELP Committee correspondence, 2025